Amarin CEO resigns; large PBM to drop Vascepa coverage July 1, affecting 25% of US volume

AMARIN CORP PLCUK

CEO Pat Holt resigned; Aaron Berg appointed as President & CEO effective June 4, 2024.
Holt will provide consulting services through July 3, 2024 in exchange for his base salary.
A large national PBM will exclude Vascepa from commercial national formularies effective July 1, 2024.
Affected formularies represent ~25% of aggregate US Vascepa prescription volume; Medicare Part D unaffected.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Aaron Berg

President and Chief Executive Officer

AMRN · AMARIN CORP PLCUK

Effective: 2024-06-04
Filed: June 4, 2024, 7:59 PM ET

Aaron Berg, who has been serving as the Company’s Executive Vice President, President U.S., has replaced Mr. Holt as President and Chief Executive Officer, effective June 4, 2024 (the “CEO Start Date”).

Appointed

Aaron Berg

Member of the Board of Directors

AMRN · AMARIN CORP PLCUK

Effective: 2024-06-04
Filed: June 4, 2024, 7:59 PM ET

Mr. Berg has been appointed as a member of the Company’s board of directors (the “Board”), effective as of the CEO Start Date.

Departed

Patrick Holt

President and Chief Executive Officer

AMRN · AMARIN CORP PLCUK

Effective: 2024-06-03
Successor: Aaron Berg
Filed: June 4, 2024, 7:59 PM ET

On June 3, 2024, Patrick Holt notified Amarin Corporation plc (the “Company”) of his decision to voluntarily resign as President and Chief Executive Officer of the Company, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Aaron Berg was appointed as President and Chief Executive Officer at AMARIN CORP PLCUK.

Action: appointed
Role: President and Chief Executive Officer

Exact text from the filing

Aaron Berg, who has been serving as the Company’s Executive Vice President, President U.S., has replaced Mr. Holt as President and Chief Executive Officer, effective June 4, 2024 (the “CEO Start Date”).

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Aaron Berg was appointed as Member of the Board of Directors at AMARIN CORP PLCUK.

Action: appointed
Role: Member of the Board of Directors

Exact text from the filing

Mr. Berg has been appointed as a member of the Company’s board of directors (the “Board”), effective as of the CEO Start Date.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Patrick Holt resigned as President and Chief Executive Officer at AMARIN CORP PLCUK.

Action: resigned
Role: President and Chief Executive Officer

Exact text from the filing

On June 3, 2024, Patrick Holt notified Amarin Corporation plc (the “Company”) of his decision to voluntarily resign as President and Chief Executive Officer of the Company, effective immediately.

View on SEC.gov

AMARIN CORP PLCUK filing history →

Source: SEC EDGAR

accession 0000950170-24-068298

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.